Advertisement
Canada markets close in 5 hours 49 minutes

  • S&P/TSX

    21,862.62
    +154.18 (+0.71%)
     

  • S&P 500

    5,012.95
    +1.83 (+0.04%)
     

  • DOW

    37,975.14
    +199.76 (+0.53%)
     

  • CAD/USD

    0.7281
    +0.0018 (+0.24%)
     

  • CRUDE OIL

    82.75
    +0.02 (+0.02%)
     

  • Bitcoin CAD

    89,089.76
    +2,808.27 (+3.25%)
     

  • CMC Crypto 200

    1,334.09
    +21.46 (+1.66%)
     

  • GOLD FUTURES

    2,395.80
    -2.20 (-0.09%)
     

  • RUSSELL 2000

    1,950.47
    +7.52 (+0.39%)
     

  • 10-Yr Bond

    4.6100
    -0.0370 (-0.80%)
     

  • NASDAQ

    15,533.27
    -68.23 (-0.44%)
     

  • VOLATILITY

    18.37
    +0.37 (+2.06%)
     

  • FTSE

    7,852.81
    -24.24 (-0.31%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6820
    -0.0001 (-0.01%)
     
MARKETS LIVE BLOG:

STOCKS OPEN MIXED AFTER ISRAEL STRIKE-FUELLED TUMBLE

Shares of Netflix, the first of the megacap techs to report, slide in early trading

Cannabis ETF (CNBS) Hits New 52-Week High

Sanghamitra Saha
·2 min read

For investors seeking momentum, Amplify Seymour Cannabis ETF (CNBS) is probably on radar. The fund just hit a 52-week high and is up 351% from its 52-week low of $6.48 per share.

But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.

CNBS in Focus

CNBS is actively managed ETF offering exposure in the fast-developing global cannabis industry. It invests 80% of its assets in securities of companies with 50% or more of their revenues from the cannabis and hemp ecosystem. The fund charges 75 bps in annual fees (see: all the World ETFs here).

Why the Move?

Marijuana stocks started February on a strong note. The latest surge came on the heels of the news that three Democratic senators led by Majority Leader Chuck Schumer said they would make reform legislation a key consideration in the current Congress, boosting hopes for a federal legalization.

More Gains Ahead?

The fund has a positive weighted alpha of 187.01. So, there is a decent outlook ahead for those who want to ride this surging ETF a shade further.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
 
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report